HIF1A and neoplasm: Hypoxia arises due to the rapid proliferation of tumor cells, which often outpaces the supply of oxygen, activating HIF-1α (hypoxia inducible factor-1α), which regulates genes that aid tumor survival, including carbonic anhydrase IX (CA IX), thereby reducing the effectiveness of anticancer treatments [4,5,6,7].